EUVIMEDSkopri EUVIMED
Systematische ÜbersichtOpen access

Conversational AI and Vaccine Communication: Systematic Review of the Evidence

Aly Passanante iD, Ed Pertwee iD, Leesa Lin iD, Kristi Yoonsup Lee iD, Joseph T Wu iD, Heidi J Larson iD

Journal of Medical Internet Research · 2023-10-03 · 25 · e42758

DOI: 10.2196/42758 ↗

At a glance

Systematische Übersicht in Journal of Medical Internet Research, published online on 2023-10-03. Written by Aly Passanante and 5 co-authors. Institution: Department of Infectious Disease Epidemiology, London School of Hygiene & Tropical Medicine, London, United Kingdom. Major MEDLINE topics: COVID-19, Vaccines. Cited 51 times so far (Crossref); 37 references. The full text is freely available in PubMed Central.

AstrattSubjectsDettalji biblijografiċiCiteRelated studies

Abstract (original language)

Background

Since the mid-2010s, use of conversational artificial intelligence (AI; chatbots) in health care has expanded significantly, especially in the context of increased burdens on health systems and restrictions on in-person consultations with health care providers during the COVID-19 pandemic. One emerging use for conversational AI is to capture evolving questions and communicate information about vaccines and vaccination.

Objective

The objective of this systematic review was to examine documented uses and evidence on the effectiveness of conversational AI for vaccine communication.

Methods

This systematic review was conducted following the PRISMA (Preferred Reporting Items for Systematic Reviews and Meta-Analyses) guidelines. PubMed, Web of Science, PsycINFO, MEDLINE, Scopus, CINAHL Complete, Cochrane Library, Embase, Epistemonikos, Global Health, Global Index Medicus, Academic Search Complete, and the University of London library database were searched for papers on the use of conversational AI for vaccine communication. The inclusion criteria were studies that included (1) documented instances of conversational AI being used for the purpose of vaccine communication and (2) evaluation data on the impact and effectiveness of the intervention.

Results

After duplicates were removed, the review identified 496 unique records, which were then screened by title and abstract, of which 38 were identified for full-text review. Seven fit the inclusion criteria and were assessed and summarized in the findings of this review. Overall, vaccine chatbots deployed to date have been relatively simple in their design and have mainly been used to provide factual information to users in response to their questions about vaccines. Additionally, chatbots have been used for vaccination scheduling, appointment reminders, debunking misinformation, and, in some cases, for vaccine counseling and persuasion. Available evidence suggests that chatbots can have a positive effect on vaccine attitudes; however, studies were typically exploratory in nature, and some lacked a control group or had very small sample sizes.

Conclusions

The review found evidence of potential benefits from conversational AI for vaccine communication. Factors that may contribute to the effectiveness of vaccine chatbots include their ability to provide credible and personalized information in real time, the familiarity and accessibility of the chatbot platform, and the extent to which interactions with the chatbot feel “natural” to users. However, evaluations have focused on the short-term, direct effects of chatbots on their users. The potential longer-term and societal impacts of conversational AI have yet to be analyzed. In addition, existing studies do not adequately address how ethics apply in the field of conversational AI around vaccines. In a context where further digitalization of vaccine communication can be anticipated, additional high-quality research will be required across all these areas.

Subjects

MeSH terms (MEDLINE)

COVID-19VaccinesHumansArtificial IntelligencePandemicsCommunication

Author keywords

COVID-19artificial intelligencechatbotsconversational AIconversational agenthealth informationvaccine communicationvaccine hesitancyvaccine information

Substances

Vaccines

Authors and institutions

  • Department of Infectious Disease Epidemiology, London School of Hygiene & Tropical Medicine, London, United Kingdom.
  • Laboratory of Data Discovery for Health, Hong Kong Science Park, Hong Kong, China (Hong Kong).
  • WHO Collaborating Centre for Infectious Disease Epidemiology and Control, School of Public Health, LKS Faculty of Medicine, The University of Hong Kong, Hong Kong, China (Hong Kong).
  • Institute for Health Metrics and Evaluation, University of Washington, Seattle, WA, United States.

ORCID profiles: Aly Passanante, Ed Pertwee, Leesa Lin, Kristi Yoonsup Lee, Joseph T Wu, Heidi J Larson

Cite

APA

Passanante, A., Pertwee, E., Lin, L., Lee, K. Y., Wu, J. T., & Larson, H. J. (2023). Conversational AI and Vaccine Communication: Systematic Review of the Evidence. Journal of Medical Internet Research, 25, e42758. https://doi.org/10.2196/42758

Vancouver

Passanante A, Pertwee E, Lin L, Lee KY, Wu JT, Larson HJ. Conversational AI and Vaccine Communication: Systematic Review of the Evidence. Journal of Medical Internet Research. 2023;25:e42758. doi:10.2196/42758

BibTeX
@article{Passanante2023,
  author = {Passanante, Aly and Pertwee, Ed and Lin, Leesa and Lee, Kristi Yoonsup and Wu, Joseph T and Larson, Heidi J},
  title = {Conversational AI and Vaccine Communication: Systematic Review of the Evidence},
  journal = {Journal of Medical Internet Research},
  year = {2023},
  volume = {25},
  pages = {e42758},
  doi = {10.2196/42758}
}
Start for free →